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Background: Extending mammalian health span and life span has been achieved under a variety of dietary
restriction protocols. Reducing the intake of a specific amino acid has also been shown to extend health and
longevity. We recently reported that methionine (MET) restriction is not effective in life span extension in growth
hormone (GH) signaling mutants. To better understand the apparent necessity of GH in the ‘sensing’ of altered
dietary MET, the current study was designed to evaluate MET and glutathione (GSH) metabolism (as well as other
pathways) in long-living GH-deficient Ames dwarf and wild-type mice following 8 weeks of restricted (0.16%), low
(0.43%), or enriched (1.3%) dietary MET consumption. Metabolite expression was examined in liver tissue, while
gene and protein expression were evaluated in liver, kidney, and muscle tissues.
Results: Body weight was maintained in dwarf mice on the MET diets, while wild-type mice on higher levels of
MET gained weight. Liver MET levels were similar in Ames mice, while several MET pathway enzymes were elevated
regardless of dietary MET intake. Transsulfuration enzymes were also elevated in Ames mice but differences in
cysteine levels were not different between genotypes. Dwarf mice maintained higher levels of GSH on MET restriction
compared to wild-type mice, while genotype and diet effects were also detected in thioredoxin and glutaredoxin. MET
restriction increased transmethylation in both genotypes as indicated by increased S-adenosylmethionine (SAM), betaine,
and dimethylglycine. Diet did not impact levels of glycolytic components, but dwarf mice exhibited higher levels
of key members of this pathway. Coenzyme A and measures of fatty acid oxidation were elevated in dwarf mice
and unaffected by diet.
Conclusions: This component analysis between Ames and wild-type mice suggests that the life span differences
observed may result from the atypical MET metabolism and downstream effects on multiple systems. The overall lack
of responsiveness to the different diets is well reflected across many metabolic pathways in dwarf mice indicating the
importance of GH signaling in the ability to discriminate dietary amino acid levels.
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Many successful efforts to extend mammalian health
span and life span have involved a variety of dietary re-
striction (DR) protocols (decreasing calories consumed)
applied to mice and rats. Altering the basic components
in the diet has also been shown to affect physiological
function and several parameters deemed important to
health and longevity. In particular, it has been shown
that reducing the amount of dietary methionine extends
the life span of normal rats by more than 30% and extends
life span in mice even when introduced midlife [1-4].
Long-living mutant mice have also benefitted from DR
intervention in terms of longevity. Ames dwarf mice live
more than 50% longer than their wild-type siblings when
fed rodent chow ad libitum [5]. The dwarfism results from
a point mutation in the Prop-1 gene that directs the differ-
entiation of anterior pituitary. While these mice lack
plasma growth hormone (GH), prolactin, and thyrotropin,
the GH deficiency is primarily responsible for the life-
extending effects [6]. Studies conducted by Bartke and
coworkers demonstrated that a 30% DR increased life
span by an additional 12% in these mice over Ames
dwarf mice fed ad libitum [7]. These observations sug-
gested that DR and GH deficiency exert different but
overlapping effects that extend health and longevity.
The health benefits of DR interventions are shared in
GH-deficient rodents and include improvements in insu-
lin sensitivity, resistance to cellular/environmental stressors,
reduced tumor incidence, delays in immune system aging,
and the development of cataracts and osteoarthritis in
many but not all studies [8-18]. Methionine restriction
similarly appears to benefit animals by reducing age-related
disorders and disease [1-3,19-23].
The long-living Ames mouse exhibits atypical methio-
nine (MET) metabolism. Multiple enzymatic components
(mRNA, proteins, activities) of this pathway are upregu-
lated in dwarf mice including methionine adenosyl-
transferase (Mat), glycine N-methyltransferase (Gnmt),
S-adenosylhomocysteine hydrolase (Ahcy), cystathio-
nine β-synthase (Cbs), and cystathionine γ-lyase (Cth)
[24-26]. The flux of methionine through the trans-
methylation and transsulfuration pathways in liver and
other tissues is also significantly higher in the Ames
mice when compared to their wild-type controls [25].
Consequently, glutathione (GSH) is elevated in multiple
tissues in young, middle-aged, and old mice [27,28].
Recently, we conducted studies to examine the effects
of different levels of dietary MET in the GH-deficient
Ames dwarf and their GH-sufficient wild-type counter-
parts. We discovered that the Ames mice do not re-
spond to changes in dietary MET in terms of life span,
body weight, or food consumption when compared to
wild-type mice [29]. To better understand the underlying
metabolic responses to altered MET as it relates to GHstatus, we undertook studies to determine the compo-
nents of the MET and GSH pathways in these animals
following 8 weeks of dietary 0.16%, 0.43%, and 1.3%
methionine. We found that in general, dwarf mice do
not discriminate the differences in dietary MET with
alterations in several metabolic pathways when com-
pared to wild-type mice.
Results
Dwarf mice maintained similar body weights regardless
of MET content in the diet and remained significantly
lower than wild-type mice (Figure 1). Across diets, dwarf
mice gained on average 3.4 g over 8 weeks. Wild-type mice
did not gain weight on the 0.16% MET diet (X = −0.53 g
between days 1 and 56) but gained 8.3 and 6.6 g over
8 weeks on the 0.43% and 1.3% diets, respectively. Simi-
larly, liver weights were maintained in dwarf mice across
diets, while higher levels of MET resulted in heavier livers
in wild-type mice corresponding with body weights
(Figure 1).
The transcriptional, translational, and enzyme activity
assays were conducted using tissues from each of the
three diets; however, the metabolomic analysis was con-
ducted using liver tissue from animals consuming the
0.16% and 1.3% MET diets only. Therefore, the data
linked to these metabolites reflects values from the same
diets. We evaluated the gene and protein expression of
MET metabolic components as well as associated metabo-
lites to understand the role of GH status. In previous stud-
ies, we have observed that mRNA levels of MET pathway
components are highly reflective of activity levels in liver
tissue. In addition, commercial antibodies were only avail-
able for some of the proteins of interest, so the corre-
sponding protein data is limited.
Changes in dietary MET intake are reflected in liver
MET metabolism. Methionine levels in Ames mouse liver
were similar regardless of dietary MET level (Figure 2).
Wild-type mice on the MET-enriched diets had similar
levels of MET to the dwarf, but MET was >50% higher in
mice on the 0.16% MET level. N-acetylmethionine, a
metabolic and nutritional equivalent of MET and reflective
of MET levels, followed an identical pattern (Additional
file 1). Methionine adenosyltransferase 1a (Mat1a) gene
expression was 100–200% higher in GH-deficient dwarf
mice across diets compared to diet-matched wild-type
mice (Figure 2, Additional file 2). In addition, the 1.3% diet
induced a 60% increase in Mat1a expression in dwarf liver
compared to the 0.16% restricted MET level. The antibody
available to examine Mat is not specific to the product of
the Mat1a gene. However, in agreement with gene expres-
sion, Mat protein levels were higher in dwarf mice regard-
less of MET intake and increased in both genotypes on
the highest level of MET (Additional file 3). Although
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Figure 1 Body and liver weights (grams) in Ames dwarf and wild-type mice following 8 weeks of 0.16%, 0.43%, or 1.3% dietary
methionine consumption. Values in bar graphs represent means ± SEM. Asterisks represent significant genotype differences within diet. ****p <
0.0001 dwarf versus wild-type mice. Colored numbers above each bar represent average gain or loss of weight from the beginning to the end of
the 8-week period.
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the two genotypes (Figure 2). SAM levels were higher
in both dwarf and wild-type mice on MET-restricted
diets compared to MET-enriched diets (78% and 120%,
dwarf and wild type, respectively). Gnmt metabolizes
SAM to S-adenosylhomocysteine (SAH). Gnmt mRNA
levels were markedly higher in dwarf mice on 0.43%
and 1.3% MET compared to diet-matched wild-type
mice (Additional file 2). Dwarf mice maintained signifi-
cantly greater amounts (86%) of SAH in MET-restricted
conditions compared to wild-type mice (Figure 2, Additional
file 2). However, higher liver SAH levels were observed in
both genotypes fed 1.3% METcompared to the 0.16% MET.
Ames mice maintained a nearly 1:1 (0.94) ratio of SAM
to SAH on MET restriction, whereas in wild-type mice,
this ratio was 1.49 (Figure 2). On enriched MET levels,
the ratio was 0.40 in dwarf and 0.31 in wild-type mice.
SAH is metabolized to homocysteine via Ahcy. The tran-
scription of the Ahcy enzyme was greater in dwarf mice
regardless of diet (Figure 2, Additional file 2). Liverhomocysteine levels were 80% lower in dwarf mice on
0.16% MET compared to wild-type mice (Figure 2). Homo-
cysteine was not affected by diet within genotype.
Homocysteine is a juncture where the utilization of
this factor can occur in either of two pathways (Figures 2
and 3). The recycling of homocysteine back to MET is sup-
ported by the metabolism of betaine to dimethylglycine,
the folate process that converts 5-methyltetrahydrofolate
(5-MeTHF) to tetrahydrofolate (THF) by methionine syn-
thase (Mtr) and the cycling of THF back to 5-THF by
5,10-methylenetetrahydrofolate reductase (Mthfr). Mtr ex-
pression was similar between genotypes on the restricted
and low (0.43%) MET diets but much higher in liver
from dwarf animals consuming the MET-enriched food
(Figure 2, Additional file 2). The levels of 5-MeTHF
and THF were unchanged by dietary MET in Ames dwarf
mice but were higher in wild-type mice on the 0.16% level
of MET (Figure 2). The Mthfr enzyme was similarly ele-
vated in dwarf mice at both the 0.16% and 1.3% MET diets
(Additional file 2). Liver betaine (trimethylglycine) levels
Figure 2 Liver metabolite (solid bars; scaled intensity) and gene expression (shaded bars; relative expression) of methionine pathway
components in Ames dwarf and wild-type mice following 8 weeks of 0.16% (red/yellow) or 1.3% (blue/green) dietary methionine
consumption. Asterisks represent significant differences between diets within a genotype. Crosses represent significant genotype differences
within a diet. Values represent means ± SEM (n = 8/genotype/diet for metabolome data; n = 10–16/genotype/diet for gene expression data).
Brown-Borg et al. Longevity & Healthspan 2014, 3:10 Page 4 of 16
http://www.longevityandhealthspan.com/content/3/1/10were significantly greater in both genotypes consuming
0.16% MET when compared to 1.3% MET but without
genotype differences. Betaine homocysteine methyltrans-
ferase (Bhmt) transcript levels were 360% and 140% higher
in dwarf mice on 0.16% and 1.3% MET compared to
wild-type mice (Figure 2, Additional file 2). The product,
dimethylglycine, mirrored betaine levels with higher
amounts found in animals consuming 0.16% MET com-
pared to MET-enriched diets. In addition, 50% more
dimethylglycine was detected in wild-type mice com-
pared to the dwarf with much lower gene expression of
Bhmt.
If homocysteine is not recycled to MET, it flows irre-
versibly through the transsulfuration pathway and is acted
upon by Cbs that combines serine and homocysteine to
form cystathionine (Figure 3). The transcript and protein
levels for liver Cbs were elevated in dwarf versus wild-type
mice regardless of the MET content of the diet (Figure 3,
Additional files 2 and 3). Transcript levels were higher inanimals consuming the MET-enriched diet. Cystathionine,
the resulting metabolite, was expressed at lower levels in
dwarf mice for all diets when compared to wild-type mice
possibly reflecting the very high transcript and protein
levels of the enzyme that follows, Cth (Figure 3, Additional
files 2 and 3). The gene expression of Cth in dwarf mice
was 120% or higher in all diets, whereas protein levels were
96%, 210%, and 38% greater than wild-type mice on 0.16%,
0.43%, and 1.3% MET, respectively (Figure 3, Additional
files 2 and 3). This enzyme is responsible for cysteine pro-
duction. Interestingly, cysteine levels were not different be-
tween genotypes but higher in wild-type mice consuming
the MET-restricted food compared to the MET-enriched
food, reflecting higher Cth protein levels within wild-type
mice across diets (Figure 3).
Cysteine generated via transsulfuration is utilized in
the generation of proteins, hydrogen sulfide, taurine, and
GSH. In GSH biosynthesis, cysteine is conjugated to glu-
tamate by the enzyme γ-glutamyl cysteine ligase (GCL)
Figure 3 Liver metabolite (solid bars; scaled intensity) and gene expression (shaded bars; relative expression) of transsulfuration,
glutathione, and taurine pathway components in Ames dwarf and wild-type mice following 8 weeks of 0.16% (red/yellow) or 1.3%
(blue/green) dietary methionine consumption. Asterisks represent significant differences between diets within a genotype. Crosses represent
significant genotype differences within a diet. Values represent means ± SEM (n = 8/genotype/diet for metabolome data; n = 10–16/genotype/diet
for gene expression data).
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of glutamate compared to wild-type mice on both diets
(Figure 4). GCL has two subunits that combine to create
the active enzyme. The transcript levels of γ-glutamyl
cysteine ligase catalytic subunit (Gclc) were twice as high
in dwarf mice fed 0.16% and 1.3% MET when compared
to wild-type mice (Additional file 2). This product in turn,
is conjugated to glycine to form GSH. Glycine levels were
not different between genotypes but greater in wild-type
mice on the 0.16% MET diets compared to the 1.3% diet
(Figure 2). Metabolomic analysis indicated that the result-
ing levels of reduced GSH were significantly lower in
wild-type mice on MET restriction compared to the levels
in wild-type mice fed 1.3% MET and to dwarf mice on ei-
ther diet (Figure 3). Dwarf mice did not differ in reduced
or oxidized GSH when fed different levels of MET. Similar
to the reduced form, wild-type mouse liver from animals
fed MET-enriched diets exhibited higher glutathione di-
sulfide (GSSG) compared to those fed MET-restricted
food. Our GSH/GSSG assay demonstrated that dwarf
mice on 0.16% MET have higher GSH than wild-typemice, and GSH and GSSG were unaltered in these mice
by different levels of MET confirming the metabolomic
data (Additional file 4). The GSH:GSSG ratios were
unaffected by diet in dwarf mice, whereas the wild-
type mouse ratios were much lower on restricted MET
compared to the enriched diets.
An additional source of cysteine is derived from the
degradation of GSH by γ-glutamyltranspeptidase (GGT).
Liver GGT activity in this study revealed lower levels of
activity in dwarf mice fed 0.43% and 1.3% MET when
compared to wild-type mice, and diet appeared to also
impact the level of GGT in this tissue (Figure 5). As a
functional correlate of GSH utilization, we determined
whether the activity of GSH S-transferase (GST) would
be altered further by changes in MET intake. MET in the
diets did not affect GST activity in dwarf mice, whereas
wild-type mice lost activity with increasing concentrations
of MET. Dwarf mice had higher DCNB GST activity than
wild-type mice on 1.3% MET (Figure 5).
Cysteine is also utilized in the formation of another
amino acid, taurine. Cysteine dioxygenase, the enzyme
Figure 4 Liver glutathione metabolites (scaled intensity) in Ames dwarf and wild-type mice following 8 weeks of 0.16% (red/yellow) or
1.3% (blue/green) dietary methionine consumption. Asterisks represent significant differences between diets within a genotype. Crosses
represent significant genotype differences within a diet. Values represent means ± SEM (n = 8/genotype/diet).
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regulated in dwarf compared to wild-type mice and in-
creased in both genotypes with increasing MET content
(Figure 3, Additional files 2 and 3). Hypotaurine levels
were increased in wild-type mice on 1.3% MET com-
pared to the dwarf (Figure 3), but dietary MET content
did not affect hypotaurine in dwarf mice. Taurine levels
were significantly increased in both genotypes on 1.3%
MET compared to animals on the 0.16% MET, but geno-
type did not appear to play a role in the levels of this
amino acid.
In past studies, the components of both oxidative and
thiol pathways were shown to differ significantly between
dwarf and wild-type mice; thus, the redoxin pathways
were examined. In liver tissue, thioredoxin 1 (Trx1) and
Trx2 in dwarf mice on the MET-enriched diets were el-
evated in comparison to diet-matched wild-type mice
(Figure 6). In the Ames mouse, Trx2 levels were also
higher at lower levels of MET. The reductases for thethioredoxins followed a very similar pattern with the
dwarf mice exhibiting high levels on MET enrichment.
When activity of Trx was examined, dwarf mice were
unaffected by MET content in the diet but had lower
levels of Trx activity compared to wild-type mice when
consuming 1.3% MET (Figure 6). Dwarf mice consum-
ing 1.3% MET exhibited greater glutaredoxin 1 (Grx1)
mRNA levels, while the activity of Grx was greater
across diets compared to wild-type mice.
Discussion
When the consumption of the essential amino acid me-
thionine is limited, the health span and life span exten-
sion of rodents is observed, similar to interventions
reducing caloric intake. Ames dwarf mice live longer
than their wild-type siblings when fed ad libitum rodent
chow, and further extensions in life span are observed
when this chow is reduced by 30% [5,7]. However, in a
recent report, we showed that dietary MET restriction
Figure 5 Liver glutathione S-transferase (GST; nmol/min*mg
protein or μmole/min*mg protein) and γ-glutamyltranspeptidase
(GGT; nmol/mg protein) activities in Ames dwarf and
wild-type mice following consumption of 0.16%, 0.43%, or
1.3% methionine for 8 weeks. Values represent means ± SEM
(n = 10–16/genotype/diet). *p < 0.05, **p < 0.01, ***p < 0.001,
and ****p < 0.0001 dwarf versus wild-type mice.
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as growth hormone receptor knockout mice suggesting
that GH signaling is necessary to discriminate amino acid
intake [29]. Indeed, the reductions of 50% and 80% MET
as well as 150% supplementation did not alter life span in
these mice nor was body weight influenced, contrary to
several other reports in normal rodents.In the current study, we fed Ames and wild-type mice
different levels of MET and examined the corresponding
metabolic pathways of MET, GSH, and redoxin to better
understand the relationships between GH deficiency and
amino acid metabolism. We focused on liver tissue as it
is the primary organ involved in MET metabolism as
well as GSH biosynthesis, detoxification, and stress resist-
ance. We also evaluated kidney as this tissue is responsible
for GSH degradation and detoxification of endogenous
and exogenous substances and has an active transsulfura-
tion system. Skeletal muscle served as a post-mitotic tissue
with limited roles in each of these systems. The results of
these two tissues are provided in Additional files 5, 6, 7, 8,
9, and 10 for tissue response comparison. The levels of
MET were chosen based on previous literature showing
that an 80% reduction extends life span (0.16%) in rodents.
The 0.43% MET level represented a 50% reduction in
typical rodent chow and a level that could be applied
in human interventional studies. We also utilized sup-
plementary MET (50% above typical levels of rodent
diet) but incorporated a level well below that shown to
be toxic (1.3%).
The body weights of dwarf mice were unaffected by
dietary MET, similar to our previous report that exam-
ined lifetime body weight on these diets. The body and
liver weight responses were reflected in the plasma insulin-
like growth factor 1 (IGF1) levels that were shown to
decrease in wild-type mice only as dietary MET levels
decreased [29]. Other investigations have shown that
body weights were either lower or unchanged by diet-
ary MET restriction [1-3,22].
In general, this study demonstrated that short-term di-
ets containing restricted, low, or enriched MET produce
vastly different liver metabolomic, mRNA, and protein
profiles in wild-type mice. Dwarf mice, however, demon-
strated fewer statistically significant differences between
diets indicating that these mice do not respond in a
similar manner to alterations in MET intake. This may
reflect the differential MET metabolism in GH-deficient
dwarf mice due to the inability to signal through the GH
pathway. This lack of responsiveness to the diets on me-
tabolite, gene, and protein levels is reflected in the lack
of a difference in life span when dwarf mice are fed these
diets throughout life (8 weeks to death) [29].
Dwarf mice did not alter liver MET or cysteine levels
in response to different levels of MET intake nor were
homocysteine levels changed in these long-living mice.
Wild-type mice generated higher levels of MET, cysteine,
and homocysteine on MET restriction compared to the
MET-enriched diet (1.3%) and in comparison to dwarf
mice (0.16%). This finding suggests the conservation of
sulfur AA possibly through recycling as the genotype
and diet differences in MET are reflected in the folate
pathway (folate, THF, 5-methyl THF). In contrast, MET
Figure 6 Gene expression (relative expression) and activity (nmol/min*mg protein) levels of liver glutaredoxin (Grx) and thioredoxin
(Trx, TrxR) in Ames dwarf and wild-type mice following 8 weeks of dietary methionine consumption. Values represent means ± SEM
(n = 10–16/genotype/diet). *p < 0.05, **p < 0.01, ***p < 0.001, and ****p < 0.0001 dwarf versus wild-type mice.
Brown-Borg et al. Longevity & Healthspan 2014, 3:10 Page 8 of 16
http://www.longevityandhealthspan.com/content/3/1/10restriction decreased sulfur amino acids in the serum
and liver of rats inducing hyperhomocysteinemia [30,31].
Wild-type mouse levels of the sulfur AA did not differfrom dwarf mice when fed a MET-enriched diet even
though all of the measured MET metabolic enzymes dif-
fered significantly in dwarf mice fed high MET. The dwarf
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restriction when compared to one another and to rats. In
response to restricted MET, folate or one-carbon metabol-
ism in wild-type mice was elevated resulting in increased
levels of MET compared to higher MET diets and to MET
restriction in dwarf mice. One report showed that post-
transcriptional downregulation of Cbs occurs when ani-
mals are fed MET-deficient diets (no MET) indicating that
a specific sensing system in mice determines when MET
intake is low and signals the liver to activate a reduction
in Cbs to conserve MET [32].
SAM is an important precursor for three key biochem-
ical pathways: methylation, transsulfuration, and poly-
amine synthesis. Mat catalyzes the formation of SAM
from MET and is upregulated in dwarf mice independ-
ent of diet agreeing with our earlier reports in these
mice fed typical rodent chow [24,25]. MET restriction
elevated SAM in both genotypes regardless of the level of
the Mat enzyme in the liver. Genotype differences in
downstream methyltransferases resulted in elevated SAH
levels in dwarf mice. SAH is metabolized to homocysteine
and adenosine via Ahcy, an enzyme that remains elevated
in Ames mice on both diets when compared to wild-type
mice. The low homocysteine levels in dwarf mice were
maintained, yet corresponding adenosine levels were ele-
vated. These observations suggest that the actions of en-
hanced Ahcy increased the levels of both products in
dwarf mice but that homocysteine was likely rapidly uti-
lized via transsulfuration as evidenced by the elevated
levels of downstream Cbs and Cth. We have previously
shown that MET flux through transsulfuration in dwarf
mouse liver occurs at three times the rate of wild-type
mice [25]. Also, the activity of Ahcy is regulated in part by
GH; thus, in the absence of this hormone, the metabolic
pathway of homocysteine may be dysregulated [33]. The
MET-conserving enzymes (MatI, Ahcy, Bhmt, Mtr, Mthfr)
tend to be inhibited by their products and other metabo-
lites, and rats fed ample MET exhibit reduced hepatic
levels of these enzymes. In dwarf mice, the opposite effect
is observed with high levels of each enzyme when con-
suming the MET-enriched diet. Wild-type mice appear
to respond to the normal feedback inhibition of the
MET-conserving enzymes. The MET-catabolizing en-
zymes, Gnmt, Cbs, and Cth, are normally activated by
the cycle metabolites, and liver levels increase with
additional MET intake. In our study, these enzymes were
higher in dwarf mice consuming the MET-enriched diet,
and Cth was also higher in the MET-restricted dwarf
when compared to their wild-type counterparts. Ahcy has
been categorized both as a MET-conserving and MET-
catabolizing enzyme as it has intermediate properties.
Under normal circumstances, the thermodynamics of this
reaction ensure the conversion of excess homocysteine to
SAH, unless the concentration of adenosine is limiting[34]. Adenosine is not limiting in the dwarf mouse in this
study. Homocysteine levels are low in dwarf mice on both
diets likely due to the upregulated gene expression and
the activities of both the MET recycling and especially the
transsulfuration pathways [24].
When MET is restricted, dwarf mice maintain lower
levels of both homocysteine and serine, which combine
to form cystathionine in reduced amounts, a reaction
catalyzed by Cbs. Cbs levels were affected by diet and
genotype, yet the resulting levels of cystathionine were un-
affected by diet. Cystathionase, also known as γ-cysteine
lyase (or CSE) expression was elevated in dwarf mice inde-
pendent of diet and similar to that found in our previous
reports suggesting further dysregulation of these pathways
in Ames mice [24,25]. Although liver cysteine levels did
not appear to differ, the manner in which cysteine was uti-
lized differed significantly by genotype. Cysteine is used for
de novo GSH biosynthesis, hypotaurine, and taurine bio-
synthesis, and it is incorporated into a variety of proteins,
as well as hydrogen sulfide. Our previous work showed
that GH-deficient dwarf mice maintain higher levels of
GSH compared to wild-type mice [35]. In the dwarf, GSH,
GSSG, and the redox pair ratio were unaltered by diet.
GSH levels in wild-type mice did not respond similarly but
matched those reported in rats showing that hepatic GSH
was low in animals fed restricted MET [1,2]. Selected
metabolite levels within the GSH pathway (including
γ-glutamyl cycle) are supportive indicating few dietary
effects in dwarf mice in contrast to wild-type mice
(Figure 4). Additionally, the dwarf mice fed 0.16%
MET maintained lower levels of many of these metab-
olites in comparison to the wild type further suggesting
that the mutant mice do not discriminate changes in
MET intake. GSH biosynthesis requires adequate amounts
of cysteine, glutamate, and glycine to maintain appropriate
levels, and each of these intersect at metabolic ‘centers’
that mirror sulfur and nitrogen metabolism, one-carbon
metabolism, and overall energy levels in a tissue [36]. The
availability of these precursors reflects the overall meta-
bolic status of cells and tissues [37].
The γ-glutamyl cycle allows GSH to serve as a con-
tinuous source of cysteine, and thus appears to contrib-
ute to the stable GSH levels in dwarf mice independent
of dietary MET intake [38]. In contrast, levels of the
γ-glutamylamino acids, 5-hydroxyproline, and GSH
are significantly impacted by MET intake in wild-type
mice conserving cysteine during low MET intake and
utilizing cysteine primarily for GSH and hypotaurine
synthesis when MET levels are high. These findings
are consistent with the increased recycling of GSH via
the γ-glutamyl cycle. As dwarf mice maintain greater
GSH under restricted MET along with the decreased
demand for growth due to GH deficiency, it makes
metabolic ‘sense’ that cysteine may be shifted toward
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GST…).
2-Hydroxybutyrate (2-OHB) is released as a byproduct
when cystathionine is cleaved to the cysteine that is in-
corporated into GSH. Elevated 2-OHB and further me-
tabolism to ophthalmate (a structural analog of GSH)
and norophthalmate reveal that restricted dietary MET
increased the abundance in wild-type mice, and enriched
MET suppressed formation in both genotypes suggesting
the conservation of cysteine for protein synthesis under
conditions of MET restriction (Figure 4). During meta-
bolic stress, cysteine is diverted from transmethylation
(to form MET) into transsulfuration to form cystathio-
nine. However, we know from MET flux studies that the
rates of transmethylation and transsulfuration are two
and three times greater, respectively, in dwarf versus
wild-type mice [25]. The enhanced MET enzyme activity
and mRNA expression help to explain the increased flux
through the transmethylation and transsulfuration path-
ways. Thus, lower levels of 2-OHB, ophthalmate, and
norophthalmate in dwarf mice consuming altered MET
diets are not reflective of the enhanced liver Gclc mRNA
observed in this study. This observation contributes to
the hypothesis that deficient GH signaling undermines
normal allosteric and regulatory mechanisms affecting
multiple metabolic pathways.
The transmethylation and MET salvage (5-methylthioa-
denosine; MTA) pathways are also involved in the regula-
tion of MET metabolism. Both SAM and MTA work to
reduce pro-growth signals including decreasing the mito-
genic effects of IGF1 [39]. MTA is part of the MET salvage
pathway that involves polyamine synthesis. The levels of
MTA tended to be lower in dwarf mice independent of diet
(Additional file 1). Others have reported that mice with in-
creased MTA have lower polyamine synthesis [40]. In turn,
ornithine levels were decreased in MET-restricted dwarf
mice compared to the wild type likely reflecting the known
stimulatory effects of GH on ornithine decarboxylase activ-
ity and polyamine synthesis [41-43]. An increase in trans-
methylation in both genotypes consuming restricted
MET is also supported by increased SAM, betaine, and
dimethylglycine. In dwarf mice, other methyltransfer-
ases, such as Gnmt and Bhmt as well as DNA methyl-
transferases, are upregulated when fed normal chow
[44,45]. Thus, the metabolite data indicate that elevated
methyltransferase enzyme function is maintained in dwarf
mice and increased in wild-type mice consuming excess
MET indicative of sensitivity to dietary MET in the pres-
ence of GH.
The first step toward cysteine utilization in the synthe-
sis of hypotaurine, taurine, and H2S occurs via cysteine
dioxygenase. In dwarf mice, increased cysteine dioxygen-
ase (CDO), Cbs, and Cth suggest increased cysteine, al-
though our metabolite analysis did not detect highercysteine levels in these mice. Hepatic protein levels of
CDO are significantly elevated in dwarf mice on normal
rodent chow (Brown-Borg, unpublished data). CDO is
expressed in high levels in rodent liver and kidney and is
strongly regulated in response to cysteine availability
such that in animals fed low protein; CDO is low (con-
serving cysteine) and is increased (up to 45-fold) in hep-
atic tissue of animals fed excess sulfur AA, to remove
high cysteine and prevent cytotoxicity [46,47]. The process
of desulfuration via CDO dominates when cysteine is defi-
cient (MET restriction), whereas oxidative catabolism
dominates when cysteine is in excess (MET enrich-
ment). When adequate sulfur AAs are provided to rats,
two thirds of cysteine catabolism is oxidative (CDO)
and one third undergoes desulfuration (Cbs, Cth). Both
the oxidative and desulfurative mechanisms of cysteine
metabolism were upregulated in Ames mice suggesting
that more cysteine is being routed through these pathways.
In addition to the enhanced antioxidative enzyme defense
observed in dwarf mice, protein glutathionylation likely
plays a role in these mice in protecting protein thiols from
oxidative-induced damage [48]. We have preliminary
evidence indicating greater glutathionylation in Ames
mice (Brown-Borg, unpublished data). Glutaredoxins
remove glutathionylated modifications from proteins,
are dependent on GSH pools, and function to maintain
a reduced state of cysteines in cellular protein [49-51].
In this study, the elevated hepatic Grx, Trx, and thiore-
doxin reductase (TrxR) reflect similar relationships be-
tween dwarf and wild-type mice reported previously
and indicate that altered MET intake does not pertur-
bate this redox system markedly [52]. In addition, GH
suppresses the activity of Grx and Trx [52]. These re-
sults support the hypothesis that deficient GH signal-
ing heightens oxidant defense mechanisms.
When the liver metabolite analysis is expanded to other
key pathways, one can observe a more global picture of
genotype and diet effects (Additional files 11 and 12). Sev-
eral components of glycolysis reveal significant genotype-
specific responses. Glucose, glucose 6-phosphate, fructose
6-phosphate, the hexose diphosphates, and glycerol
3-phosphate were higher in dwarf compared to wild-
type mice while other glycolytic metabolites (glycerate,
PEP, 3-phosphoglycerate, lactate) were lower (Additional
file 11). However, different levels of dietary MET did not
impact levels of the measured glycolytic components in
either genotype. These findings are in contrast to those
reported in calorie restriction where the glycolytic
pathway was downregulated, and acetyl CoA was un-
altered when compared to ad libitum-fed animals [53].
Major components within the Krebs cycle appeared to
be similarly unaffected by diet suggesting that MET in-
take does not impact their functioning, that metabolite
levels are not indicative of function, or that the static
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ations (Additional file 12).
Coenzyme A is an indispensible cofactor in all organ-
isms functioning as an acyl carrier and carbonyl activat-
ing groups in key metabolic pathways including the
Krebs cycle and fatty acid metabolism [54]. Many thiol-
containing proteins are elevated in dwarf mice including
GSH, metallothionein, GSH peroxidase, and selenopro-
tein R (Msrb), and now, we show that the thiol, coen-
zyme A, is also higher in dwarf mice regardless of diet
(Additional file 12) [55]. These high levels are in concert
with the enhanced fat utilization suggested by low respira-
tory quotients observed in dwarf mice [56,57]. Long-term
MET restriction increases energy expenditure limiting fat
deposition despite increased food intake suggesting that
these diets lead to increased metabolic flexibility [22].
Since dwarf mice already appear to rely on fat as a meta-
bolic fuel (RQ < 1 and high VO2), an additional mechan-
ism, such as restricted MET intake, may not further
impact these systems. These conditions in dwarf mice
likely reflect the increased energy demand for thermo-
genesis [57,58]. Fatty acid metabolism was impacted by
restricted MET in wild-type mice but not in dwarf
mice suggesting that the reduced mobilization of fatty
acids from lipid stores with low MET may be dependent
on GH signaling. Glycerophospholipid metabolism was
also driven by restricted dietary MET in a GH-dependent
manner with several phospholipid metabolites elevated in
MET restriction compared to MET enrichment in wild
type but not in dwarf mice (data not shown). Supporting
evidence indicating enhanced fatty acid oxidation is de-
rived from studies showing that PGC1-α, PPAR-α, acyl-
CoA oxidase (rate-limiting enzyme in β-oxidation), Cyp4a,
and others are significantly elevated in dwarf versus wild-
type mice [59-61].
Many aspects of mitochondrial function are altered in
the long-living Ames mice. The OXPHOS enzymes are
upregulated, liver mitochondrial H2O2 production is re-
duced, and both cytosolic and mitochondrial antioxidative
enzymes are increased providing the basis for the
lower oxidative damage levels to DNA and proteins
[55,62]. MET is sensitive to ROS-mediated oxidation,
and the product MET sulfoxide is reduced back to
MET by thioredoxin. The increased potential for repair
of protein oxidative damage is suggested by higher
Msrb protein levels and the increased Trx in dwarf
mice [35]. The dwarf maintained lower levels of me-
thionine sulfoxide levels possibly due to altered Trx
and Grx (Additional file 1).
Several differences in metabolite levels that report on
glucose metabolism were observed with diet in wild-type
mice (Additional file 11). Glucose and the six-carbon
glycolytic intermediates, fructose 6-phosphate, fructose
1,6-diphosphate, and myo-inositol (1,4 or 1,3)-diphosphatewere lower with MET restriction compared to MET
enrichment. Glucose polymers that arise from glyco-
gen metabolism (maltopentaose, maltotetraose, malto-
triose, and maltose) were significantly lower in wild-type
mice consuming 0.16% MET compared to those fed
1.3% MET (data not shown). These metabolites are
thought to be reflective of glycogen breakdown [63].
The pentose phosphate pathway metabolites (ribose-5-
phosphate, ribulose-5-phosphate, xylulose-5-phosphate,
ribulose) were also lower with the 0.16% diet (data not
shown).
Although all of the liver metabolomic data is not pre-
sented, in total, the data indicates that dwarf mice are
able to maintain their distinctive MET metabolism des-
pite changes in MET levels as indicated by relatively few
diet-specific alterations when compared to wild-type mice.
The responsiveness of the wild-type mouse is reflected in
changes in life span when fed altered MET and much like
previous studies.
Conclusions
In dwarf mice, the altered expression of key MET pathway
enzymes results in a lack of dietary MET effects on homo-
cysteine, serine, cysteine, cystathionine, GSH, hypotaurine,
MET, THF, folate, and homoserine among others. This
component analysis between dwarf and wild-type mice
suggests that the life span differences observed in these
mice may result from the atypical MET metabolism and
downstream effects on multiple systems in dwarf mice.
The increased MET flux, β-oxidation, and glycolytic flux
are consistent with high CoA levels. One limitation of our
study is that each parameter was measured once across
genotypes on each diet representing a snapshot, whereas a
more dynamic picture would include multiple measures
over time. However, we believe that the overall lack of re-
sponsiveness to the different diets is well reflected across
many metabolic pathways in the Ames mice. In addition,
some of the differences observed may also reflect the dif-
ferential composition of the specialized diets compared to
data generated with animals fed standard rodent chow.
Thus, the Ames mice exhibit a distinct metabolic signa-
ture during MET restriction and MET enrichment, differ-
ing from wild-type mice, yet the responsiveness to altered
MET intake was minimal in comparison. We and others
have shown that many of the MET pathway components
as well as related pathways (antioxidative enzymes, GSH,
stress resistance among others) are influenced by GH sta-
tus. We believe that the lack of responsiveness of the
Ames mice to altered MET intake, at least in part, results
from their GH deficiency. Our results suggest that GH
signaling impacts dietary amino acid responsiveness and
ability to alter life span. Altered MET intake profoundly
impacted liver metabolism in GH-sufficient wild-type
mice only.
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Animals
Ames dwarf mice were derived from a closed colony
with a heterogeneous background (over 30 years) at the
University of North Dakota (UND). Dwarf mice were
generated by mating either homozygous (df/df) or het-
erozygous (df/+) dwarf males with carrier females (df/+).
All mice were bred and maintained at the UND Center
for Biomedical Research under controlled conditions of
photoperiod (12:12 h light/dark cycle) and temperature
(22 ± 1°C) and ad libitum access to food (birth to 8 weeks
of age; Teklad #8640) and water. Male animals were
started on the methionine diets at 8 weeks of age (in
staggered cohorts). Animal procedures were reviewed
and approved by the UND Institutional Animal Care
and Use Committee following the Guide for the Care
and Use of Laboratory Animals (NRC, 2011). A total of
40 wild-type and 38 dwarf mice were utilized for these
studies. Body weights were determined immediately prior
to tissue collection.
Diets
Three levels of methionine (016%, 0.43%, 1.3% MET)
were incorporated into amino acid-defined diets that
were manufactured by Harlan Teklad based on the AIN-
93 diet (TD.10230, TD.10231, TD.10232). In each of the
diets, glutamic acid was adjusted to keep the diets isoni-
trogenous (suggested by manufacturer, Harlan Laboratories,
Madison, WI). L-methionine was the only source of sulfur
amino acids in these diets. A restricted level of 0.16% MET
was used based on the literature demonstrating life span
extension in rodents and to avoid issues of rectal prolapse
and early mortality that have been previously reported [3].
The 0.43% MET diet represented about 50% of the
MET found in many of the rodent chows, and a level
of methionine that might be more achievable in human
diets. An increase of 50% above normal chow levels repre-
sented an enriched MET diet (1.3%) yet supplementing
this amino acid below the reported level of toxicity
[64,65]. Sulfathiazole supplementation was not provided
in these diets.
Methionine and glutathione metabolism
Liver tissue was collected from Ames dwarf and wild-
type mice following 8 weeks on the diets (n = 10–16/
genotype/diet), rapidly frozen, and stored at −80°C until
analysis (food was not removed the night before collec-
tion). Kidney and hind limb skeletal muscle tissue were
also collected from the same animals, but the data de-
rived from these tissues is presented only in the add-
itional files for comparison to liver. For enzyme assays,
tissue samples were homogenized on ice with a Bullet
Blender in buffer (20 mM MOPS, 300 mM sucrose,
and 0.1 mM EDTA at pH 7.2; Next Advance, AverillPark, NY). Homogenates were centrifuged for 30 min
at 13,000 g and the supernatant fractions used for ana-
lysis following the determination of protein concentra-
tions. The supernatants were used to determine the
enzyme activities of glutathione S-transferase, GGT,
and glutaredoxin using the spectrophotometric method
of Holmgren [66-69]. Thioredoxin activity was mea-
sured by its ability to reduce insulin disulfide in the
presence of NADPH and thioredoxin reductase [69,70]. For
each assay, the absorbance was read at 340 nm, appropriate
blanks were subtracted from total absorbance, and the ac-
tivity was calculated. The cellular oxidation state was deter-
mined by measuring the ratio of the specific reduction/
oxidation pair, GSH/GSSG using procedures described by
Griffith and employed in our laboratory [26,71].
Gene expression was evaluated in tissues using stand-
ard real-time RT-PCR techniques as previously reported
[26,50]. Total RNA was extracted and equal amounts of
RNA for the gene of interest (all used annealing temper-
atures at 62°C) and the reference gene, β2 microglobulin
(β2M-annealing at 60°C), were utilized to perform one-
step real-time semi-quantitative PCR using a QuantiTect
SYBR Green RT-PCR kit (Qiagen). The gene-specific
forward and reverse primers utilized are listed in Table 1.
Gene expression was determined as previously described
using the comparative CT method. The amount of target
DNA was normalized to the endogenous reference gene
and compared relative to the control group (diet-matched
wild-type mice).
Immunoblotting was utilized to evaluate protein levels
of various components of the glutathione and methio-
nine pathways. Standard techniques previously devel-
oped and published were employed [44,52]. Antibodies
to mouse Gclm, Ahcy, Cbs, Mat, Trx1, Trx2, TrxR1,
and TrxR2 were obtained from Proteintech (Chicago, IL).
Bhmt, Cth, and Gnmt antibodies were obtained from
Santa Cruz Biotechnology (Santa Cruz, CA), and Grx was
purchased from R & D Systems (Minneapolis, MN). The
CDO antibody was supplied by Abcam (Cambridge, MA).
Chemiluminescence (Bio-Rad; Hercules, CA) and densitom-
etry (Omega-Lum, Aplegen) were used for the detection and
analysis of protein levels [28]. The Ponceau-S staining of
membranes was used to evaluate equal loading of protein.
Metabolomics
To gain more specific information regarding the response
of the liver tissue to the effects of dietary methionine, we
examined a broad spectrum of molecules using a non-
targeted metabolomic approach. Liver tissues from ani-
mals consuming the 0.16% and 1.3% MET diets (n = 8/
genotype/diet) were evaluated by Metabolon, Inc. (Re-
search Triangle Park, NC). The tissues were processed
using published procedures for protein precipitation
and aliquoted for evaluation using three different mass
Table 1 Primer sets (5′-3′) used for real-time PCR analysis of gene expression
Gene of interest GenBank accession # Forward primer Reverse primer
Methionine adenosyltransferase 1a (Mat1a) NM_133653 ctgaggcgctctggtgtc tcctgcatgtactgaactgttacc
Glycine N-methyltransferase (Gnmt) NM_010321 gctggacgtagcctgtgg cacgctcatcacgctgaa
S-adenosylhomocysteine hydrolase (Ahcy) NM_016661 ctgttggggttcacttcctg acattcagcttgcccaggt
Cystathionine β-synthase (Cbs) NM_144855 cgcacaggaaggactgcta agccttcacagccacagc
Cystathionase (Cth) NM_145953 gagtctggctgagcttcca cgagggtagctctgtccttc




5,10-Methylenetetrahydrofolate reductase (Mthfr) NM_010840 agcttgaagccacctggactgtat agactagcgttgctgggtttcaga
Glutamylcysteine ligase catalytic subunit (Gclc) NM_010295 ggaggcgatgttcttgagac cagagggtcggatggttg
Glutamylcysteine ligase modifier subunit (Gclm) NM_008129 gactcacaatgacccgaaaga gatgctttcttgaagagcttcct
Thioredoxin 1 (Trx1) X77585 cgtggtggacttctctgctacgtggtg ggtcggcatgcatttgacttcacagtc
Thioredoxin 2 (Trx2) U85089 gctagagaagatggtcgccaagcagca tcctcgtccttgatccccacaaacttg
Thioredoxin reductase 1 (TrxR1) AB027565 ggccaacaaaatcggtgaacacatggaag cgccagcaacactgtgttaaattcgccct
Thioredoxin reductase 2 (TrxR2) AB027566 gtcccctcccacatcaaaaaactcccaac ggcccacaggacagtgtcaaaggtgc
Glutaredoxin 1 (Grx1) AB013137 tgcagaaagacccaagaaatcctcagtca tggagattagatcactgcatccgcctatg
Glutaredoxin 2 (Grx2) NM_023505 catcctgctcttactgttccatggccaa tcatcttgtgaagcgcatcttgaaactgg
β2-microglobulin (B2M) NM_00975 atgggaagccgaacatactg cagtctcagtgggggtgaat
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raphy/mass spectrometry (LC/MS) was performed using a
Waters Acquity UPLC system and a Thermo-Finnigan LTQ
mass spectrometer, including an electrospray ionization
(ESI) source and linear ion trap (LIT) mass analyzer. Ali-
quots of each vacuum-dried sample were reconstituted,
one each in acidic or basic LC-compatible solvents con-
taining eight or more injection standards at fixed concen-
trations (to both ensure injection and chromatographic
consistency). Extracts were loaded onto columns (Waters
UPLC BEH C18-2.1 × 100 mm, 1.7 μm) and gradient
eluted with water and 95% methanol containing 0.1% for-
mic acid (acidic extracts) or 6.5 mM ammonium bicar-
bonate (basic extracts). Samples for gas chromatography/
MS (GC/MS) analysis were dried under vacuum desicca-
tion overnight prior to being derivatized under nitrogen
using bistrimethyl-silyl-trifluoroacetamide (BSTFA). Deri-
vatized samples were separated on a 5% diphenyl/95% di-
methyl polysiloxane fused silica column (20 m × 0.18 mm
ID; 0.18 μm film thickness) with helium as carrier gas and
a temperature ramp from 60°C to 340°C in a 17.5-min
period and then analyzed on a Thermo-Finnigan Trace
DSQ fast-scanning single-quadrupole mass spectrometer
using electron impact (EI) ionization. The mass accuracy
and calibration of the instrument were checked daily.
Quality control measures included using columns and re-
agents from a single lot to complete all related experi-
ments, the randomization of experimental samples and
controls throughout each day’s run, the use of pooled ex-
perimental samples serving as technical replicates (forprecision calculations) throughout the analyses, extracted
water samples serving as process blanks, and a cocktail of
standards spiked into every sample to monitor instrument
performance.
The metabolites were identified by comparing the experi-
mental samples to a reference library of purified chemical
standards using chromatographic properties and mass
spectra matching to the specific compound or an isobaric
entity using proprietary visualization and interpretation
software [74]. Library matches for each compound were
verified for each sample. The liver metabolome consisted
of 348 named biochemicals. In this analysis, the median
relative standard deviation for the internal standards
(instrument variability) was 4% and for the endogenous
biochemicals (total process variability) was 12%.
Statistics
For the gene expression, immunoblotting, activity assays,
and metabolomic data comparisons, a two-way analysis
of variance and, when appropriate, Bonferroni post hoc
testing as well as Tukey’s were used to determine sig-
nificant differences among means (Prism GraphPad, San
Diego, CA). Data are reported as means ± SEM.
Additional files
Additional file 1: Figure S1. Liver metabolites (scaled intensity) of
supporting components in Ames dwarf and wild-type mice following
8 weeks of 0.16% (red/yellow) or 1.3% (blue/green) dietary methionine
consumption. Asterisks represent significant differences between diets
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within a diet. Values represent means ± SEM (n = 8/genotype/diet for
metabolome data).
Additional file 2: Figure S2. Liver gene expression (relative expression)
of methionine, transsulfuration, and glutathione pathway components in
Ames dwarf and wild-type mice following 8 weeks of 0.16%, 0.43%, or
1.3% dietary methionine consumption. Values represent means ± SEM
(n= 10–16/genotype/diet). *p< 0.05, **p< 0.01, ***p< 0.001, and ****p< 0.0001
dwarf versus wild-type mice.
Additional file 3: Figure S3. Liver protein levels (relative optical density
units) of Mat, Cbs, Cth, Gclm, and CDO in Ames dwarf and wild-type mice
following 8 weeks of 0.16%, 0.43%, or 1.3% dietary methionine consumption.
Values represent means ± SEM (n= 11–12/genotype/diet). *p< 0.05, **p < 0.01,
***p< 0.001, and ****p< 0.0001 dwarf versus wild-type mice.
Additional file 4: Table S4. Liver, kidney, and skeletal muscle
glutathione (GSH) and glutathione disulfide (GSSG) in Ames dwarf and
wild-type mice following 8 weeks of dietary methionine consumption
(0.16%, 0.43%, 1.3%). Values represent means ± SEM (n = 10–16/genotype/
diet). *p < 0.05, **p < 0.01, and ****p < 0.0001 dwarf versus wild-type mice.
Additional file 5: Supporting information. Supporting text for
Additional files 6, 7, 8, 9, and 10 describing the kidney and muscle tissue
responses to altered MET diet consumption.
Additional file 6: Figure S6. Kidney gene expression (relative
expression) of methionine, transsulfuration, and glutathione pathway
components in Ames dwarf and wild-type mice following 8 weeks of
0.16%, 0.43%, or 1.3% dietary methionine consumption. Values represent
means ± SEM (n = 10–16/genotype/diet). *p < 0.05, **p < 0.01, ***p < 0.001,
and ****p < 0.0001 dwarf versus wild-type mice.
Additional file 7: Figure S7. Kidney glutathione S-transferase (GST;
nmol/min*mg protein) and γ-glutamyltranspeptidase (GGT; nmol/min*mg
protein) activities in Ames dwarf and wild-type mice following consumption
of 0.16%, 0.43%, or 1.3% methionine for 8 weeks. Values represent
means ± SEM (n = 11–16/genotype/diet). **p < 0.01 and ****p < 0.0001
dwarf versus wild-type mice.
Additional file 8: Figure S8. Gene expression (relative expression) and
activity (nmol/min*mg protein) levels of kidney glutaredoxin (Grx) and
thioredoxin (Trx, TrxR) in Ames dwarf and wild-type mice following
8 weeks of dietary methionine consumption. Values represent means ±
SEM (n = 10–16/genotype/diet). *p < 0.05, **p < 0.01, ***p < 0.001, and
****p < 0.0001 dwarf versus wild-type mice.
Additional file 9: Figure S9. Skeletal muscle gene expression (relative
expression) of methionine pathway components in Ames dwarf and
wild-type mice following 8 weeks of 0.16%, 0.43%, or 1.3% dietary methionine
consumption. Values represent means ± SEM (n = 10–16/genotype/diet).
*p < 0.05, **p < 0.01, ***p< 0.001, and ****p < 0.0001 dwarf versus wild-type
mice.
Additional file 10: Figure S10. Gene expression (relative expression)
levels of skeletal muscle glutaredoxin (Grx) and thioredoxin (Trx, TrxR) in
Ames dwarf and wild-type mice following 8 weeks of dietary methionine
consumption. Values represent means ± SEM (n = 10–16/genotype/diet).
*p < 0.05, **p < 0.01, and ****p < 0.0001 dwarf versus wild-type mice.
Additional file 11: Figure S11. Liver glycolysis and pentose phosphate
metabolites (scaled intensity) in Ames dwarf and wild-type mice following
8 weeks of 0.16% (red/yellow) or 1.3% (blue/green) dietary methionine
consumption. Asterisks represent significant differences between diets
within a genotype. Crosses represent significant genotype differences
within a diet. Values represent means ± SEM (n = 8/genotype/diet).
Additional file 12: Figure S12. Liver Krebs cycle metabolites (scaled
intensity) in Ames dwarf and wild-type mice following 8 weeks of 0.16%
(red/yellow) or 1.3% (blue/green) dietary methionine consumption. Asterisks
represent significant differences between diets within a genotype. Crosses
represent significant genotype differences within a diet. Values represent
means ± SEM (n= 8/genotype/diet).
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